Acurx Pharmaceuticals, Inc.
ACXP
$4.08
$0.225.70%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -4.52% | 22.74% | 1.41% | 31.54% | 5.85% |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -7.51% | -17.59% | 15.39% | -62.08% | 2.53% |
Change in Net Operating Assets | 147.77% | -4,842.86% | -104.24% | 1,401.82% | -90.42% |
Cash from Operations | 18.57% | 8.84% | -2.77% | 23.97% | 5.96% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 3.42% | 1,436.61% | -87.78% | 397.03% | -92.90% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 3.42% | 1,436.61% | -87.78% | 397.03% | -92.90% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 51.54% | 145.59% | -243.62% | 76.63% | -276.96% |